Advanced Biotechnologies Inc.
Advanced Biotechnologies Inc. provides you with high quality viral reagents for research and development processes.
Microbiology Product Areas
ClinicalNOTE: The products listed in this section may not be approved for clinical diagnostic use in your jurisdiction. You must assume these products are unregulated and therefore cannot be used for routine testing and reporting of results unless otherwise stated. | ||
| Herpes Simplex Virus | Show all suppliers | |
| HIV | Show all suppliers | |
| Influenza | Show all suppliers | |
| Influenza H1N1 | Show all suppliers | |
| Respiratory Syncytial Virus (RSV) | Show all suppliers | |
Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!
LATEST MICROBIOLOGY NEWS
- The Emergence of Lateral Flow Assays in Diagnostics
- AOAC RI Approval of BAX® System Assays for Detection of STEC and Salmonella from Sampling Cloths
- Pathogen Testing in Low-Moisture Foods
- Endotoxin and Pyrogen Test Kits and Software - a rapidmicrobiology Special Focus
- Why Ultrapure Water is Essential for Consistent, Reproducible Endotoxin Results
- Testing Your Medical Devices with Endotoxin-Free Pipette Tips
- Microbiology Proficiency Tests for TOC and Endotoxins
- Hot Sale - Norovirus (NoV) Genotype GI/GII PCR Detection Kit
- Charles River Redefines Smart Automation with the Endosafe® Nexus 200™
- BioChek® Offers Smart Veterinary Diagnostics Including PCR Solutions
MICROBIOLOGY EVENTS
- 30th International Biodetection Technologies
- How Crucial is Culture Media Selection in Environmental Monitoring? A Roundtable Discussion
- How Crucial is Culture Media Selection in Environmental Monitoring? A Roundtable Discussion
- My Green Lab 2023 Summit
- Rapid Point of Care Test Development Workshop 2023
- SAE Media Group's 5th Annual Pharmaceutical Microbiology West Coast
- Updates on IFU Methods and ISO Standards for Beverages
- Cell and Gene Therapy
- 2023 PDA Virus Conference
- Driving Process Automation, Affordability & Scalability for Global Cell Therapies